Earnings Feed
Start Free
Odyssey Therapeutics, Inc.·4

May 11, 8:32 PM ET

Haas Jason 4

Research Summary

AI-generated summary

Updated

Odyssey Therapeutics (ODTX) CFO Jason Haas Buys 1,000 Shares

What Happened
Jason Haas, Chief Financial Officer of Odyssey Therapeutics (ODTX), purchased 1,000 shares on May 8, 2026 at $20.00 per share for a total transaction value of $20,000. The transaction is reported as a purchase (Form 4 code P), described as an open-market or private purchase.

Key Details

  • Transaction date: 2026-05-08
  • Filing date (Form 4): 2026-05-11 (timely)
  • Shares purchased: 1,000
  • Price per share: $20.00
  • Total value: $20,000
  • Transaction type: Purchase (open-market/private purchase), Form 4 code P
  • Shares owned after transaction: Not specified in the supplied filing excerpt
  • No footnotes or 10b5-1 plan details provided in the supplied data

Context
Insider purchases (especially by senior officers) are often viewed by investors as a generally positive sign, though a single small purchase — $20k in this case — is modest and not definitive on its own. For full ownership figures and any additional notes, consult the complete Form 4 on SEC EDGAR.